Dr. Mantripragada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3686 S Rome St
Gilbert, AZ 85297Phone+1 480-890-7705Fax+1 480-398-8095
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
- BronxCare Health SystemResidency, Internal Medicine, 2008 - 2011
- Western Kentucky UniversityMPH, Biostatistics, Occupational Health, 2005 - 2007
- Rangaraya Medical College NTRClass of 2004
Certifications & Licensure
- AZ State Medical License 2017 - 2025
- CA State Medical License 2010 - 2020
- RI State Medical License 2011 - 2018
- MA State Medical License 2015 - 2015
Awards, Honors, & Recognition
- FACP American College of Physicians, 2015
- Best Outgoing Medical Student NTR University of Health Sciences, 2004
- Best Outgoing Medical Student Indian Academy of Sciences, Hyderabad, 2004
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsResponse to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and PancreasKalyan Mantripragada, Ariel E. Birnbaum
Cureus. 2015-12-13 - 15 citationsFOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.Howard Safran, Kevin P. Charpentier, Kimberly Perez, Kalyan Mantripragada, Thomas J. Miner
American Journal of Clinical Oncology. 2016-12-01 - 18 citationsLenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study.Howard Safran, Kevin P. Charpentier, Andreas Kaubisch, Kalyan Mantripragada, Gregory Dubel
American Journal of Clinical Oncology. 2015-02-01
Abstracts/Posters
- Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II StudySafran H, Charpentier KP, Kaubisch A, Mantripragada K, Dubel G, Perez K, Faricy-Anderson K, Miner T, Eng Y, Victor J, Plette A, Espat J, Bakalarski P, Wingate P, Berz ..., ASCO 2012, Chicago, USA
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Telugu, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: